News
- Author:
- Marlene Busko
Publish date: August 18, 2023
“We uncovered compelling evidence that for blood sugar levels within the ‘normal’ range, it was a case of ‘the lower the better’ in protecting agai...
News
- Author:
- Marlene Busko
Publish date: August 16, 2023
“These findings are the first of their kind and provide new insights into the mechanisms of weight regain.”
News
- Author:
- Marlene Busko
Publish date: August 15, 2023
Five days of water fasting lowered weight by about 6%, but this weight was regained after 3 months of regular eating.
News
- Author:
- Marlene Busko
Publish date: August 9, 2023
Ultraprocessed foods are usually nutrient-poor, high in calories, added sugar, sodium, and unhealthy fats.
News
- Author:
- Marlene Busko
Publish date: August 1, 2023
“The platform is completely generic and has immense potential for deployment at the point of need ...”
News
- Author:
- Marlene Busko
Publish date: July 28, 2023
“The practice of combination therapy will grow as [metabolic and bariatric surgery] and [antiobesity medications] work in synergy.”
News
- Author:
- Marlene Busko
Publish date: July 25, 2023
Weight loss is recommended for patients with knee osteoarthritis (KOA), and GLP-1 RAs are approved for weight loss. Early research suggests these d...
News
- Author:
- Marlene Busko
Publish date: July 17, 2023
The main reason that more patients with lower BMIs are not being offered surgery is related to insurance coverage and reimbursement, one expert say...
News
- Author:
- Marlene Busko
Publish date: July 5, 2023
The hybrid closed-loop system is not available in the United States but other systems are available and sometimes used off label in pregnancy....
News
- Author:
- Marlene Busko
Publish date: July 5, 2023
Survodutide has received U.S. Food and Drug Administration Fast Track Designation for adults with NASH.
News
- Author:
- Marlene Busko
Publish date: June 26, 2023
“These data support further investigation of CagriSema in people with type 2 diabetes in longer and larger phase 3 studies.”
News
- Author:
- Marlene Busko
Publish date: June 26, 2023
OASIS-1 showed that “oral semaglutide 50 mg may represent an effective option for the treatment of obesity, particularly in patients who prefer ora...
News
- Author:
- Marlene Busko
Publish date: June 26, 2023
“Diabetes distress is the emotional response to living with diabetes, the burden of relentless daily self-management, and the prospect of its long-...
News
- Author:
- Marlene Busko
Publish date: June 13, 2023
“I would say, overall, the jury is still out,” as to whether anecdotal reports of GLP-1 agonists curbing addictions will be borne out in randomized...
News
- Author:
- Marlene Busko
Publish date: June 9, 2023
“By making a small adjustment to the carb content of a single meal rather than the entire diet, we have the potential to increase adherence signifi...
